Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)

Health and Quality of Life Outcomes

Volumn 14, Issue 1, 2016, Pages

  Golabi, Pegah ^a   Otgonsuren, Munkhzul ^a   Cable, Rebecca ^b   Felix, Sean ^a   Koenig, Aaron ^a   Sayiner, Mehmet ^a   Younossi, Zobair M ^a,b  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADL DISABILITY; ADULT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HEALTH CARE SURVEY; HEALTH STATUS; HEART DISEASE; HEPATITIS C; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; POPULATION RESEARCH; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RACE; SEX DIFFERENCE; SOCIAL STATUS; AGE; ATTITUDE TO HEALTH; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COPING BEHAVIOR; MIDDLE AGED; NUTRITION; PSYCHOLOGY; QUESTIONNAIRE; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; ATTITUDE TO HEALTH; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION SURVEYS; QUALITY OF LIFE; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84960090322     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-016-0420-z     Document Type: Article

References (20)

1. Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol. 2012;18:1508-16.
2. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol. 2014;5:277-86.
3. Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, et al. Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States from 2004-2009. Hepatology. 2015. doi: 10.1002/hep.28123.
4. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263-73.
5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-23.
6. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547-55.
7. Younossi ZM, Henry L. Economic and quality-of-life implications of Non-alcoholic fatty liver disease. Pharmacoeconomics. 2015;33(12):1245-53. doi: 10.1007/s40273-015-0316-5. PMID: 26233836.
8. Newton JL. Systemic symptoms in non-alcoholic fatty liver disease. Dig Dis. 2010;28:214-9.
9. Mahmood S. Assessment of health related quality of life in chronic liver disease patients using the Japenese versions of CLDQ and SF-36. Open Gastroenterol J. 2008;2:57-63.
10. Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013;15:301.
11. Younossi ZM, Stepanova M, Nader F, Lam B, Hunt S. The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life. Aliment Pharmacol Ther. 2015;42:286-95.
12. Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26:815-20.
13. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30:469-76.
14. Newton JL, Pairman J, Wilton K, Jones DE, Day C. Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res. 2009;19:319-26.
15. Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut. 2008;57:807-13.
16. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther. 2012;36:772-81.
17. Kallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007;52:2531-9.
18. Cinar S, Ozdogan OC, Alahdab Y. Impact of education provided by nurses on quality of life, anxiety, and depression in patients receiving hepatitis C virus therapy. Gastroenterol Nurs. 2015;38(5):343-7.
19. Fabregas BC, de Avila RE, Faria MN, Moura AS, Carmo RA, Teixeira AL. Health related quality of life among patients with chronic hepatitis C: a cross-sectional study of sociodemographic, psychopathological and psychiatric determinants. Braz J Infect Dis. 2013;17:633-9.
20. Teuber G, Schafer A, Rimpel J, Paul K, Keicher C, Scheurlen M, et al. Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis. J Hepatol. 2008;49:923-9.